Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to daratumumab?” Dr. Jatin Shah from the University of Texas MD Anderson Cancer Center responds to this question and goes on to discuss promising treatment options in clinical trials, specifically related to immunotherapy and checkpoint inhibitors.
Can High-Risk Myeloma Patients Become... - Myeloma America S...
Can High-Risk Myeloma Patients Become Refractory to Certain Monoclonal Antibodies?
Written by
mcints
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Zoom Zoom, CAR-T Cells to Treat Myeloma
An exciting approach to refractory myeloma is the development of CAR-T cells to recognize and kill...
multiple myeloma on pancreatic and pelvic as extramedullary plasmacytoma
Our Mayo Clinic psychiatrist mentioned most cancer patients have the treatment of maintenance...
NEWLY DIAGNOSED WITH MM
After five years of potassium depletion and leg and shoulder pain my new Oncologist has just...
